Approval · Notice of Compliance 4429 · 1996
GEMFIBROZIL: Notice of Compliance 4429
Issued December 23, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4429
- Date
- December 23, 1996
- Company
- Omni Laboratories Division, Warner-Lambert Canada Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihyperlipidemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEMFIBROZIL | 00851922 | Cancelled Post Market |
| GEMFIBROZIL | 00851930 | Cancelled Post Market |
Medicinal ingredients
- GEMFIBROZIL 300 MG per CAP
- GEMFIBROZIL 600 MG per TAB